Harry Hyman
Chief Executive Officer
Election to the Board - Harry Hyman founded the Company in 1996 and served on the Board as Managing Director from that time and represented the former Adviser to the Company, Nexus Tradeco Limited (“Nexus”), on the Board. On completion of the internalisation on 5 January 2021, Harry was appointed as Chief Executive Officer. As announced on 2 November 2023, subject to shareholder approval Harry will be appointed as Non-executive Chair with effect from the end of the 2024 AGM. The Board believes that Harry’s appointment is in the best interests of the Group and all of its stakeholders, particularly as his knowledge and expertise gained over nearly 30 years in the primary care property sector will continue to be invaluable and highly relevant to the Group’s future success. The Board has determined that the term will be a maximum of three years.
Career - Harry graduated from Cambridge University and trained as a Chartered Accountant and Corporate Treasurer. He established the Company in 1996 and was the Managing Director of Nexus Tradeco Limited (“Nexus”), which until 5 January 2021 was the Adviser to PHP. He is a Fellow of the Institute of Chartered Accountants in England and Wales, a Fellow of the Association of Corporate Treasurers and a Fellow of the Royal Institute of Chartered Surveyors.
Skills, competence and experience - Harry has extensive experience in investing in the primary healthcare sector, having developed the Company’s business from inception over 20 years ago to its current position with an investment portfolio of over £2.6 billion. He also brings entrepreneurial flair to the Board having established a number of successful private companies.
Other listed directorships - Non-executive Chairman of Biopharma Credit Plc, an externally managed investment trust which invests in the fast-growing science industry, and of TMT Acquisition PLC, an acquisition shell company, both of which are listed on the London Stock Exchange.
Independent Non-executive - Not applicable
